Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Zuchero JY"'
Autor:
Xia D; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lianoglou S; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Sandmann T; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Calvert M; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Suh JH; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Thomsen E; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Dugas J; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., DeVos SL; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lin CC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Davis S; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Ha C; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Nguyen H; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Chau R; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Yulyaningsih E; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lopez I; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Masoud ST; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Liang CC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lin K; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Astarita G; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Khoury N; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Zuchero JY; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA.; Department of Pharmaceutics, University of Minnesota, 9-177 Weaver-Densford Hall, 308 Harvard St. SE, Minneapolis, MN, 55455, USA., Shen K; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Miller S; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Palop JJ; Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA., Garceau D; The Jackson Lab, Bar Harbor, Maine, USA., Sasner M; The Jackson Lab, Bar Harbor, Maine, USA., Whitesell JD; Allen Institute for Brain Science, Seattle, Washington, USA., Harris JA; Allen Institute for Brain Science, Seattle, Washington, USA., Hummel S; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Gnörich J; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Wind K; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Kunze L; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Zatcepin A; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Brendel M; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Willem M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany., Haass C; German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig- Maximilians-Universität, München, 81377, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377, Munich, Germany., Barnett D; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA., Zimmer TS; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA., Orr AG; Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY, USA.; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, USA., Scearce-Levie K; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Di Paolo G; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA., Sanchez PE; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, California, 94080, USA. sanchez@dnli.com.
Publikováno v:
Molecular neurodegeneration [Mol Neurodegener] 2022 Jun 11; Vol. 17 (1), pp. 41. Date of Electronic Publication: 2022 Jun 11.
Autor:
Gadkar K; Preclinical and Translational Pharmacokinetics Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Yadav DB; Preclinical and Translational Pharmacokinetics Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Zuchero JY; Department of Neuroscience, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Couch JA; Safety Assessment Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Kanodia J; Preclinical and Translational Pharmacokinetics Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Kenrick MK; Preclinical and Translational Pharmacokinetics Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Atwal JK; Department of Neuroscience, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Dennis MS; Antibody Engineering Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Prabhu S; Preclinical and Translational Pharmacokinetics Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Watts RJ; Department of Neuroscience, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Joseph SB; Preclinical and Translational Pharmacokinetics Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Ramanujan S; Preclinical and Translational Pharmacokinetics Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: ramanujan.saroja@gene.com.
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2016 Apr; Vol. 101, pp. 53-61. Date of Electronic Publication: 2016 Jan 25.
Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody.
Autor:
Faresjö, Rebecca1 (AUTHOR), Sehlin, Dag1 (AUTHOR), Syvänen, Stina1 (AUTHOR) stina.syvanen@pubcare.uu.se
Publikováno v:
Fluids & Barriers of the CNS. 5/11/2023, Vol. 20 Issue 1, p1-17. 17p.
Autor:
Su, Shiran1,2 (AUTHOR), Esparza, Thomas J.1,3,4 (AUTHOR), Brody, David L.1,2,3,5 (AUTHOR) david.brody@nih.gov
Publikováno v:
PLoS ONE. 10/18/2022, Vol. 17 Issue 10, p1-31. 31p.
Publikováno v:
Expert Review of Clinical Pharmacology; Oct2023, Vol. 16 Issue 10, p977-990, 14p
Autor:
Zhang, Wandong1 (AUTHOR) Wandong.Zhang@nrc-cnrc.gc.ca, Liu, Qing Yan1 (AUTHOR), Haqqani, Arsalan S.1 (AUTHOR), Leclerc, Sonia1 (AUTHOR), Liu, Ziying2 (AUTHOR), Fauteux, François2 (AUTHOR), Baumann, Ewa1 (AUTHOR), Delaney, Christie E.1 (AUTHOR), Ly, Dao1 (AUTHOR), Star, Alexandra T.1 (AUTHOR), Brunette, Eric1 (AUTHOR), Sodja, Caroline1 (AUTHOR), Hewitt, Melissa1 (AUTHOR), Sandhu, Jagdeep K.1 (AUTHOR), Stanimirovic, Danica B.1 (AUTHOR) Danica.Stanimirovic@nrc-cnrc.gc.ca
Publikováno v:
Fluids & Barriers of the CNS. 7/22/2020, Vol. 17 Issue 1, p1-17. 17p.
Publikováno v:
Journal of Pharmacokinetics & Pharmacodynamics; Jun2022, Vol. 49 Issue 3, p337-362, 26p
Autor:
Ma, Jiabing, Mo, Yicheng, Tang, Menglin, Shen, Junjie, Qi, Yanan, Zhao, Wenxu, Huang, Yi, Xu, Yanmin, Qian, Cheng
Publikováno v:
Frontiers in Immunology; 5/5/2021, Vol. 12, pN.PAG-N.PAG, 19p
Autor:
Kiseleva, R. Yu., Glassman, P. G., LeForte, K. M., Walsh, L. R., Villa, C. H., Shuvaev, V. V., Myerson, J. W., Aprelev, P. A., Marcos-Contreras, O. A., Muzykantov, V. R., Greineder, C. F.
Publikováno v:
FASEB Journal; Sep2020, Vol. 34 Issue 9, p11577-11593, 13p
Publikováno v:
Journal of Pharmacokinetics & Pharmacodynamics; Aug2019, Vol. 46 Issue 4, p319-338, 20p